|
Volumn 6, Issue 5, 1997, Pages 505-508
|
CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic nod mice
a,e a a b d d c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
GLUCOSE;
INSULIN;
INSULIN ANTIBODY;
POLYLYSINE;
STREPTOZOCIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
GRAFT REJECTION;
GRAFT SURVIVAL;
IMMUNOHISTOCHEMISTRY;
INSULIN RELEASE;
INTRAPERITONEAL DRUG ADMINISTRATION;
MICROENCAPSULATION;
MOUSE;
NEWBORN;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
SCID MOUSE;
STREPTOZOCIN DIABETES;
SWINE;
XENOGRAFT;
ANIMALS;
ANIMALS, NEWBORN;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION;
CELL SURVIVAL;
CELLS, CULTURED;
DIABETES MELLITUS, TYPE 1;
DRUG COMPOUNDING;
IMMUNOCONJUGATES;
IMMUNOSUPPRESSIVE AGENTS;
INSULIN;
ISLETS OF LANGERHANS TRANSPLANTATION;
MICE;
MICE, INBRED NOD;
PERITONEAL CAVITY;
RECOMBINANT FUSION PROTEINS;
SWINE;
TRANSPLANTATION, HETEROLOGOUS;
ANIMALIA;
SUIDAE;
SUS SCROFA;
|
EID: 0030823355
PISSN: 09636897
EISSN: None
Source Type: Journal
DOI: 10.1016/S0963-6897(97)00045-6 Document Type: Article |
Times cited : (47)
|
References (31)
|